DXVX (180400) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for DXVX (180400:KRX), powered by AI.

Current Price
₩2,610
P/E Ratio
-8.6
Market Cap
249.0B
Sector
Unknown
What is the DXVX stock price forecast?

DXVX is currently trading at ₩2,610. View real-time AI analysis on Alpha Lenz.

What is DXVX insider trading activity?

View the latest insider trading data for DXVX on Alpha Lenz.

What is DXVX's P/E ratio?

DXVX's P/E ratio is -8.6.

DXVX

KRX · 180400
₩2,610+80(+3.16%)Market closedKRX regular session 09:00–15:30 KST
Ask about DXVX's future dividend policy...
Alpha Chat Insight

DXVX trades at a P/E of -8.6 (undervalued) with modest ROE of -53.8%.

Ask for details

Company Overview

Dx & Vx Co., Ltd. is a dynamic entity within the biotechnology and pharmaceutical sectors. The company is primarily involved in the development and manufacturing of diagnostics and vaccines, playing a crucial role in global health. Its product portfolio includes a range of innovative solutions designed to detect and combat infectious diseases, thereby addressing significant public health challenges. Dx & Vx Co., Ltd. is notable for its focus on cutting-edge technologies and collaborations, seeking to enhance its offerings through strategic alliances and research partnerships. This focus positions the company as a key player in the advancement of medical solutions aimed at disease prevention and management. In the financial markets, Dx & Vx Co., Ltd. is recognized for its potential impact on healthcare outcomes globally, particularly through its contributions to both preventive and responsive medical treatments. Its operations are crucial not only in opening new avenues for medical intervention but also in supporting global initiatives towards health security and disease eradication.

CEO이용구, 권규찬 (각자 대표이사)
SectorUnknown
IndustryUnknown
0

Company Statistics

FY 2025

Profile

₩249,026,462,960Market Cap
₩29,356,591,140Revenue
98.43MShares Out
0Employees

Margins

11.31%Gross
-86.35%EBITDA
-82.85%Operating
-108.96%Pre-Tax
-100.78%Net

Valuation

-8.58P/E
2.65P/B
8.48EV/Sales
-7.71EV/EBITDA
-12.29P/FCF

Growth (CAGR)

-3.02%Rev 3Yr
30.70%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-26.04%ROA
-53.82%ROE
-25.69%ROIC

Financial Health

₩103,434,383,520Cash & Cash Equivalents
₩-44,324,949,710Net Debt
61.72%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

DXVX (ticker: 180400) is a company listed on KRX in the Unknown sector (Unknown). Market cap is $249.0B.

The current price is ₩2,610 with a P/E ratio of -8.58x and P/B of 2.65x.

ROE is -53.82% and operating margin is -82.85%. Annual revenue is $29.4B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
DXVX (180400) Stock Forecast 2026 ₩2,610 — Price, Financials & Analyst Targets | Alpha Lenz